Gel4Med Expands Acute-Care Market Access for G4Derm™ Plus Biomimetic Matrix

Collaboration with Summit Products Group and MiMEDX to accelerate hospital-system availability and adoption of advanced wound care solution.

Feb. 9, 2026 at 6:07pm

Got story updates? Submit your updates here. ›

Gel4Med, Inc., a leader in advanced biomaterials engineering, announced expanded acute-care and surgical-suite market access for its G4Derm™ Plus Biomimetic Matrix (BMM™) through a distribution collaboration with Summit Products Group and MiMEDX Group, Inc. The partnership aims to leverage MiMEDX's established Surgical & Wound Care channel capabilities to broaden clinician and patient access to the advanced wound care solution.

Why it matters

The collaboration represents an important step in Gel4Med's strategy to advance its peptide-based biomaterials across surgical and wound care indications. By working with Summit and MiMEDX, Gel4Med can expand availability of G4Derm™ Plus, which is designed to support tissue regrowth and manage bioburden in complex wound environments.

The details

Under the agreement, Summit Product Group will distribute G4Derm™ Plus alongside MiMEDX's portfolio of surgical and wound care products. MiMEDX brings deep clinical and commercial expertise, including established GPO and IDN contracting capabilities, strengthening the collaboration's ability to expand patient access to G4Derm™ Plus across the acute-care setting.

  • The collaboration was announced on February 5, 2026.

The players

Gel4Med, Inc.

A leader in advanced biomaterials engineering and a pioneer in next-generation peptide-based technologies.

Summit Products Group

A multi-solution surgical wound care supplier dedicated to advancing healing through science, strategic partnerships, and commercialization expertise.

MiMEDX Group, Inc.

A Marietta, Georgia-based company with a portfolio of surgical and wound care products designed to help clinicians manage chronic and other hard-to-heal wounds.

Manav Mehta

CEO of Gel4Med.

Got photos? Submit your photos here. ›

What they’re saying

“Gel4Med was founded to create the next generation of biomaterials that not only support tissue regrowth, but also address bioburden management in complex wounds. This is a scale moment for G4Derm™ Plus. By working in lockstep with Summit and leveraging MiMEDX's reach in surgical reconstruction & wound care management, we can broaden access to clinicians and patients who need advanced options in complex wound environments.”

— Manav Mehta, CEO of Gel4Med

What’s next

The collaboration is designed to accelerate hospital-system availability and adoption of G4Derm™ Plus by leveraging established Surgical & Wound channel capabilities.

The takeaway

This partnership allows Gel4Med to expand access to its innovative G4Derm™ Plus Biomimetic Matrix, which is designed to support tissue regrowth and manage bioburden in complex wound environments, through the established distribution and contracting capabilities of Summit Products Group and MiMEDX.